Metformin
| Price | $15 |
| Package | 10G |
| Min. Order: | 10G |
| Supply Ability: | Ex 20 tons |
| Update Time: | 2022-09-15 |
Product Details
| Product Name: Metformin | CAS No.: 657-24-9 |
| EC-No.: 211-517-8 | Min. Order: 10G |
| Purity: 99% | Supply Ability: Ex 20 tons |
| Release date: 2022/09/15 |
| Description | Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin can cross the blood-brain barrier and triggers autophagy[1]. |
|---|---|
| Related Catalog | Signaling Pathways >> Epigenetics >> AMPK Research Areas >> Cardiovascular Disease Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> PI3K/Akt/mTOR >> AMPK Signaling Pathways >> Autophagy >> Mitophagy Research Areas >> Metabolic Disease |
| Target | AMPK |
| In Vitro | Metformin (1,1-Dimethylbiguanide) inhibits proliferation of ESCs in a concentration-dependent manner. The IC50 is 2.45?mM for A-ESCs and 7.87?mM for N-ESCs. Metformin shows pronounced effects on activation of AMPK signaling in A-ESCs from secretory phase than in cells from proliferative phase[3]. Metformin (0-500 μM) decreases glycogen synthesis in a dose-dependent manner with an IC50 value of 196.5 μM in cultured rat hepatocytes[4]. Metformin shows cell viability and cytotoxic effects on PC-3 cells with IC50 of 5 mM[5]. |
| In Vivo | Metformin (1,1-Dimethylbiguanide; 100 mg/kg, p.o.) alone, and metformin (25, 50, 100 mg/kg) with isoproterenol groups attenuates myocyte necrosis through histopathological analysis[1]. Metformin (> 900 mg/kg/day, p.o.) results in moribundity/mortality and clinical signs of toxicity in Crl:CD(SD) rats[2]. |
| Solvent | In Vivo: 1.Metformin is dissolved in PBS at 300 mM and stored at -20°C. The working solution of metformin is freshly prepared[1]. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Shipping | Room temperature |
| SMILES | NC(NC(N(C)C)=N)=N |
| References | [1]. Soraya H, et al. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacol Rep. 2012;64(6):1476-84. [2]. Quaile MP, et al. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7. [3]. Xue J, et al. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction. 2013 Aug 21;146(4):397-406. [4]. Otto M, et al. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94. [5]. Avci CB, et al. Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(2):765-8. |
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $39.00/10mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-16 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $30.00/100g |
VIP1Y
|
Shenzhen Aoxi Technology Co., Ltd.
|
2025-03-24 | |
| $0.00/25KG |
VIP1Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-03-12 | |
| $10.00/1kg |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-23 | |
| $0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-05-13 | |
| $0.00/1kg |
Henan Suikang Pharmaceutical Co.,Ltd.
|
2024-04-26 | ||
| $8.00/1kg |
VIP2Y
|
Henan Fengda Chemical Co., Ltd
|
2024-04-03 | |
| $160.00/1kg |
Guangzhou Tengyue Chemical Co., Ltd.
|
2023-06-28 | ||
| $5.00/1g |
Hebei Endun Biological Technology Co. LTD
|
2023-03-15 |
China- Since: 2022-02-24
- Address: 3-1-1005, Federal Business Plaza, 166 Yuhua West Road, Qiaoxi District, Shijiazhuang City, Hebei Pro
+86-19831998802
106@hebeianda.cn